Expression of OP4 (ORL1, NOP1) receptors in vascular endothelium

European Journal of Pharmacology

Volumn 482, Issue 1-3, 2003, Pages 17-23

  Granata, Filippo ^a   Potenza, Rossella Luisa ^a,b   Fiori, Anna ^a   Strom, Roberto ^a   Caronti, Brunella ^c   Molinari, Paola ^b   Donsante, Sonia ^c   Citro, Gennaro ^d   Iacovelli, Luisa ^a,e   De Blasi, Antonio ^e   Ngomba, Richard T ^e   Palladini, Guido ^c   Passarelli, Francesca ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e IRCCS NEUROMED   (Italy)

Author keywords

Aorta; Endothelial cell; Immunocytochemistry; In situ hybridization; MAP (mitogen activated protein) kinase; OP4 receptor

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NOCICEPTIN; OPIATE RECEPTOR; OPIOID LIKE RECEPTOR 1; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULAR RING;

EID: 0345167936     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.09.049     Document Type: Article

References (30)

1. Abbott N.J., Hughes C.C., Revest P.A., Greenwood J. Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J. Cell. Sci. 103:1992;23-37.
2. Bacic F., McCarron R.M., Uematsu S., Spatz M. Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium. Metab. Brain Dis. 7:1992;125-137.
3. Bouchelet I., Cohen Z., Case B., Seguela P., Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol. Pharmacol. 50:1996;219-223.
4. Calò G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129:2000;1261-1283.
5. Cardelli P., Fiori A., Corleto V.D., Savi M.R., Granata F., Ceci F., Ferraguti G., Potenza R.L., Delle Fave G., Jensen R.T., Strom R. Inhibitory effect of somatostatin on neutral amino acid transport in isolated brain microvessels. J. Neurochem. 78:2001;349-357.
6. Champion H.C., Pierce R.L., Kadowitz P.J. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat. Regulatory Pept. 78:1998;69-74.
7. 3H]nociceptin binding site in membrane preparations of rat heart: correlations with the non-opioid dynorphin binding site. Mol. Cell. Cardiol. 30:1998;2751-2760.
8. Giuliani S., Tramontana M., Lecci A., Maggi C.A. Effect of nociceptin on heart rate and blood pressure in anaesthetized rats. Eur. J. Pharmacol. 333:1997;177-179.
9. Guillot F.L., Audus K.L. Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability. J. Cardiovasc. Pharmacol. 18:1991;212-218.
10. Gutkind J.S. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene. 17:1998;1331-1342.
11. Herrington C.S., Mc Gee J.O. Principles and basic methodology of DNA/RNA detection by in situ hybridization. Herrington C.S., McGee J.O. Diagnostic Molecular Pathology: A Practical Approach. vol. 1:1992;69-102 IRL Press, New York, NY.
12. Hugghins S.Y., Champion H.C., Cheng G., Kadowitz P.J., Jeter J.R. Vasorelaxant responses to endomorphins, nociceptin, albuterol, and adrenomedullin in isolated rat aorta. Life Sci. 67:2000;471-476.
13. Kummer W., Fischer A. Nociceptin and its receptor in guinea-pig sympathetic ganglia. Neurosci. Lett. 234:1997;35-38.
14. Lin B., Waterman R., Lipton H. Nociceptin receptor activation produces nitric oxide-mediated systemic hypotension. Life Sci. 66:2000;99-104.
15. Lou L.G., Zhang Z., Ma L., Pei G. Nociceptin/orphanin FQ activates mitogen-activated protein kinase in Chinese hamster ovary cells expressing opioid receptor-like receptor. J. Neurochem. 70:1998;1316-1322.
16. Luscher T.F. Endothelial control of vascular tone and growth. Clin. Exp. Hypertens., Part A Theory Pract. 12:1990;897-902.
17. Malinowska B., Godlewski G., Schlicker E. Function of nociceptin and opioid OP4 receptors in the regulation of the cardiovascular system. J. Physiol. Pharmacol. 53:2002;301-324.
18. Marshall C.J. Specificity of receptor tyrosine kinase signalling: transient vs. sustained activated protein kinase. J. Neurochem. 65:1995;1823-1833.
19. Masaki T., Miwa S., Sawamura T., Ninomiya H., Okamoto Y. Subcellular mechanisms of endothelin action in vascular system. Eur. J. Pharmacol. 375:1999;133-138.
20. Menzies J.R., Glen T., Davies M.R., Paterson S.J., Corbett A.D. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13) NH(2) in the mouse and rat colon and the mouse vas deferens. Eur. J. Pharmacol. 385:1999;217-223.
21. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
22. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53:2001;381-415.
23. Mollereau C., Mouledous L., Lapalu S., Cambois G., Moisand C., Butour J.L., Meunier J.C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
24. Neal M.J., Cunningham J.R., Paterson S.J., McKnight A.T. Inhibition by nociceptin of the light-evoked release of ACh from retinal cholinergic neurones. Br. J. Pharmacol. 120:1997;1399-1400.
25. Scriba G.K., Borchardt R. Metabolism of catecholamine esters by cultured bovine brain microvessel endothelial cells. J. Neurochem. 53:1989;610-615.
26. Stanimirovic D.B., Bertrand N., Merkel N., Bembry J., Spatz M. Interaction between histamine and adenosine in human cerebromicrovascular endothelial cells: modulation of second messengers. Metab. Brain Dis. 9:1994;275-289.
27. Stefano G.B., Hartman A., Bilfinger T.V., Magazine H.I., Liu Y., Casares F., Goligorsky M.S. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270:1995;30290-30293.
28. Traish A.M., Kim N., Carson M.P., de Tejada I.S. Characterization of muscarinic acetylcholine receptors in cultured bovine aortic endothelial cells. J. Recept. Res. 14:1994;153-166.
29. Wick M.J., Minnerath S.R., Roy S., Ramakrishnan S., Loh H.H. Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Mol. Brain Res. 32:1995;342-347.
30. Xie G.X., Meuser T., Pietruck C., Sharma M., Palmer P.P. Presence of opioid receptor-like (ORL1) receptor mRNA splice variants in peripheral sensory and sympathetic neuronal ganglia. Life Sci. 64:1999;2029-2037.